Proton beam therapy for recurrent ovarian carcinoma: A case report.
proton beam
radiation therapy
recurrent ovarian carcinoma
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
05
12
2018
accepted:
25
05
2019
pubmed:
25
7
2019
medline:
11
2
2020
entrez:
24
7
2019
Statut:
ppublish
Résumé
The efficacy and feasibility of proton beam therapy (PBT) for recurrent ovarian carcinoma had not been determined. Here we presented a case of recurrent ovarian carcinoma that was successfully treated with PBT. A 48-year-old woman who was diagnosed as left ovarian clear cell carcinoma underwent surgery without removal of two tumors. After achieving complete remission with postoperative chemotherapy, a recurrent tumor was found in the sigmoid colon, for which a colostomy was performed. Because second-line chemotherapy was not effective, PBT was selected; there were no complications, except for a transient low-grade fever. After 1 year of PBT, the tumor completely disappeared and the patient had been disease-free for over 8 years. PBT may be an effective and less invasive treatment modality for recurrent ovarian carcinoma.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1952-1956Informations de copyright
© 2019 Japan Society of Obstetrics and Gynecology.
Références
Mitin T, Zietman AL. Promise and pitfalls of heavy-particle therapy. J Clin Oncol 2014; 32: 2855-2863.
de Felice F, Marchetti C, di Mino A et al. Recurrent ovarian cancer the role of radiation therapy. Int J Gynecol Cancer 2017; 27: 690-695.
Eifel PJ. Role of radiation therapy. Best Pract Res Clin Obstet Gynaecol 2017; 41: 118-125.
Curran WJ Jr, Whittington R, Peter AJ, Fanning J. Vaginal recurrences of endometrial carcinoma: The prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 1988; 15: 803-808.
Einhorn N, Trope C, Ridderheim M, Boman K, Sorbe B, Cavallin-Stahl E. A systemic overview of radiation therapy effects in ovarian cancer. Acta Oncol 2003; 42: 562-566.
Dang YZ, Li X, Ma YX et al. 18F- FDG PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study. Oncol Lett 2019; 17: 149-158.
Machida S, Takei Y, Yoshida C et al. Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancer. Oncology 2014; 86: 232-238.
Chang JS, Kim SW, Kim YJ et al. Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial. Gynecol Oncol 2018; 151: 39-45.
Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol 2013; 130: 300-305.
Okamoto A, Glasspool RM, Mabuchi S et al. Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer 2014; 24: S20-S25.
Westhoff GL, Fuh KC, Longacre TA et al. Radiation therapy for recurrent clear-cell cancer of the ovary. Int J Gynecol Cancer 2016; 26: 1608-1614.
Baskar R, Lee KA, Yeo R, Yeoh K-W. Cancer and radiation therapy: Current advances and future directions. Int J Med Sci 2012; 9: 193-199.
Boon IS, Au Yong TPT, Boon CS. Assessing the role of artificial intelligence (AI) in clinical oncology: Utility of machine learning in radiotherapy target volume delineation. Medicines (Basel) 2018; 5: 131.
Verma V, Simone CB II, Wahl AO, Beriwal S, Mehta MP. Proton radiotherapy for gynecologic neoplasms. Acta Oncol 2016; 55: 1257-1265.